+971.7%
MRNA vs CRL
+152.3%
+819.4%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CRL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -1.6% | +2.9% | +2.0% |
| 7D | -13.8% | -3.8% | -10.1% | -12.3% |
| 30D | -17.7% | +4.0% | -21.6% | -19.6% |
| 3M | +14.3% | +13.1% | +1.2% | +7.8% |
| 6M | +336.0% | +115.1% | +220.8% | +219.2% |
| YTD | +575.9% | +64.4% | +511.5% | +445.9% |
| 1Y | +724.4% | +102.9% | +621.5% | +515.0% |
| 3Y | +160.8% | +73.5% | +87.3% | +99.2% |
| 5Y | -24.4% | -13.7% | -10.8% | -31.9% |
| All | +971.7% | +152.3% | +819.4% | +761.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CRL.
Daily Out/Under-Performance
Portfolio return minus CRL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CRL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CRL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling